IRIS
DE STEFANO, ALFONSO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 521
EU - Europa 313
AS - Asia 200
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 510
IT - Italia 118
CN - Cina 95
SG - Singapore 95
NL - Olanda 60
IE - Irlanda 38
UA - Ucraina 33
FI - Finlandia 32
CI - Costa d'Avorio 27
CA - Canada 11
SE - Svezia 10
DE - Germania 8
IN - India 7
CZ - Repubblica Ceca 6
BE - Belgio 4
GB - Regno Unito 2
JP - Giappone 2
BG - Bulgaria 1
EU - Europa 1
FR - Francia 1
ID - Indonesia 1
Totale 1.062
Salva come PNG Salva come JPEG
Città #
Chandler 112
Singapore 80
Amsterdam 58
Millbury 35
Beijing 34
Princeton 29
Ashburn 27
Napoli 23
Nanjing 20
Naples 18
Santa Clara 15
Boston 11
Ottawa 11
Des Moines 9
Lentini 9
Nanchang 9
Shenyang 8
Tianjin 7
Casoria 6
Jiaxing 6
Munich 6
Wilmington 6
Olomouc 5
Washington 5
Indiana 4
Jacksonville 4
Milan 4
Helsinki 3
Acerra 2
Afragola 2
Boardman 2
Courcelles 2
Edegem 2
Hicksville 2
Houston 2
Messina 2
New York 2
Norwalk 2
Pune 2
Redwood City 2
San Mateo 2
Villarosa 2
Ameno 1
Augusta 1
Cagliari 1
Camparada 1
Casalnuovo 1
Castellana Grotte 1
Changchun 1
Changsha 1
Chengdu 1
Edinburgh 1
Espoo 1
Falls Church 1
Formia 1
Hebei 1
Jakarta 1
Kronberg 1
Kunming 1
Lawrence 1
Los Angeles 1
Montesilvano Marina 1
Mountain View 1
Newbury Park 1
Ogliastro Cilento 1
Orange 1
Prague 1
Redmond 1
Rome 1
San Jose 1
Sant'antonio Abate 1
Seattle 1
Secunderabad 1
Serra 1
Tokyo 1
Turin 1
Viareggio 1
Totale 627
Salva come PNG Salva come JPEG
Nome #
STATO DELL'ARTE SULLA CHEMIOTERAPIA NEL CANCRO DEL COLON 83
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 62
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 56
Bevacizumab related arterial hypertension as a predictive marker in metastatic Colorectal Cancer (mCRC) patients 44
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 44
Bevacizumab as 4th line treatment in metastatic colorectal cancer 43
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 43
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 43
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 40
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 39
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer 38
Double complete response in MCRC patient 38
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? 38
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: tolerability, and prognostic factors. 37
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients 37
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools 36
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS 33
Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al (2015) 33
Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer 31
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer 31
Correlation between bevacizumab-related hypertension and response in mCRC patients 30
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 30
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 30
Bevacizumab maintenance in metastatic colorectal cancer: How long? 27
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 26
Neoadjuvant treatment with capecitabine and oxaliplatin in combination with radiotherapy for rectal cancer patients: a phase II study 25
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer 24
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 23
Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer 22
Surgery in lung cancer metastasis 22
Totale 1.108
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.164
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.164
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 3 1 0 3 0 12 27 9
2020/202167 1 3 6 5 4 14 9 4 11 2 6 2
2021/2022221 3 1 2 4 1 11 1 7 48 23 47 73
2022/2023284 31 15 9 19 29 31 0 30 45 59 13 3
2023/2024166 4 27 29 13 6 19 0 29 0 1 22 16
2024/2025131 42 43 4 11 31 0 0 0 0 0 0 0
Totale 1.108